Prevalence of autoimmune thyroid disease and thyroid dysfunction in young Brazilian patients with type 1 diabetes

2008 ◽  
Vol 9 (4pt1) ◽  
pp. 272-276 ◽  
Author(s):  
Jacqueline Araujo ◽  
Lucas AC Brandão ◽  
Rafael L Guimarães ◽  
Sérgio Santos ◽  
Elcy A Falcão ◽  
...  
2020 ◽  
Vol 10 (4-s) ◽  
pp. 112-119
Author(s):  
Walid Hassene HAMRI ◽  
Mustapha DIAF ◽  
Noria HARIR ◽  
Mohamed HADJ HABIB

Background and Objectives: Epidemiological inquiries on the subclinical atherosclerotic disease in type 1 diabetes associated with autoimmune thyroid disease are scarce. Our aim was to evaluate the risk of developing atherosclerosis via lipid ratios by comparing two groups of patients according to their TSH (Thyroid-stimulating hormone) status. Methods: A retrospective study including 190 patients (13-74 years) with confirmed type 1 diabetes divided into the following groups (patients with serum TSH < 2.5 μIU/mL vs. patients with serum TSH ≥ 2.5 μIU/mL). Autoimmune thyroid disease was classified according to clinical, biological, and follow up data. Results: Our study showed a slight predominance of females (50.50%), with an average age of 29.25±11.39 years. The prevalence of hypothyroidism was 14.7%, hyperthyroidism 6.3%, and anti-TPO 16.31%. Significant differences were observed between lipid profiles such as HDL and TG (p= 0.008; p=0.04, respectively). The results showed that the 3rd (OR= 2.28 [0.72-7.20]; p=0.15) and the fourth quartiles (OR= 1.9 [0.61-5.83]; p=0.26) of TC/HDL ratio were higher in patients with serum TSH ≥ 2.5 μIU/mL group. Similarly, we noticed higher concordant values on the last quartile (4th) of LDL/HDL ratio with p values of 0.06 as well as the two quartiles (2ndand 4th) of TG/HDL ratio with p values of 0.03 and 0.04, respectively. In both groups, lipid ratios were slightly higher in males compared to females’ patients. Conclusion: The risk of atherosclerosis was higher in patients with elevated TSH concentrations. Therefore, early detection of thyroid dysfunction and associated dyslipidemia is essential for effective prevention of premature cardiovascular morbidity and mortality. Keywords: Subclinical atherosclerotic disease, autoimmune thyroid disease, TSH, type 1 diabetes


2015 ◽  
Vol 2015 ◽  
pp. 1-3
Author(s):  
Stefano Benedini ◽  
Antonietta Tufano ◽  
Elena Passeri ◽  
Marco Mendola ◽  
Livio Luzi ◽  
...  

Type 1 diabetes mellitus (T1D), autoimmune thyroid disease, and autoimmune gastritis often occur together forming the so-called autoimmune polyendocrine syndrome type 3 (APS3). We here report a clinical case of a 74-year-old woman who presented for the first time with severe hyperglycemia and ketoacidosis diagnosed as T1D. Further clinical investigations revealed concomitant severe hypothyroidism with autoimmune thyroid disease and severe cobalamin deficiency due to chronic atrophic gastritis. The diagnosis of type 1 diabetes mellitus was confirmed by the detection of autoantibodies against glutamic acid decarboxylase 65, islet cell antibodies, and anti-insulin autoantibodies. Anti-thyroperoxidase, anti-thyroglobulin, and anti-gastric parietal cell antibodies were also clearly positive. The case emphasized that new onset diabetic ketoacidosis, hypothyroidism, and cobalamin deficiency may simultaneously occur, and one disease can mask the features of the other, thereby making diagnosis difficult. It is noteworthy that an APS3 acute episode occurred in an asymptomatic elder woman for any autoimmune diseases.


Author(s):  
Berglind Jonsdottir ◽  
Christer Larsson ◽  
Annelie Carlsson ◽  
Gun Forsander ◽  
Sten Anders Ivarsson ◽  
...  

2020 ◽  
Vol 11 ◽  
pp. 204201882095832
Author(s):  
Liyan Li ◽  
Shudong Liu ◽  
Junxia Yu

Autoimmune thyroid disease (AITD) and type 1 diabetes mellitus (T1DM) are two common autoimmune diseases that can occur concomitantly. In general, patients with diabetes have a high risk of AITD. It has been proposed that a complex genetic basis together with multiple nongenetic factors make a variable contribution to the pathogenesis of T1DM and AITD. In this paper, we summarize current knowledge in the field regarding potential pathogenic factors of T1DM and AITD, including human leukocyte antigen, autoimmune regulator, lymphoid protein tyrosine phosphatase, forkhead box protein P3, cytotoxic T lymphocyte-associated antigen, infection, vitamin D deficiency, and chemokine (C-X-C motif) ligand. These findings offer an insight into future immunotherapy for autoimmune diseases.


2000 ◽  
Vol 15 (3) ◽  
pp. 202-210 ◽  
Author(s):  
Yong Soo Park ◽  
Won Bae Kim ◽  
Tae Wha Kim ◽  
Bo Youn Cho

Sign in / Sign up

Export Citation Format

Share Document